Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease

Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease

Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous corona...

Full description

Bibliographic Details
Main Authors: Michael Megaly, Marwan Saad, Emmanouil S Brilakis
Format: Article
Language:English
Published: Radcliffe Medical Media 2019-01-01
Series:US Cardiology Review
Online Access:https://www.uscjournal.com/articleindex/usc.2019.4.1
id doaj-5fa0cc149b4b475c9d3140cdd71076aa
record_format Article
spelling doaj-5fa0cc149b4b475c9d3140cdd71076aa2021-10-09T16:01:10ZengRadcliffe Medical MediaUS Cardiology Review 1758-38961758-390X2019-01-01131162010.15420/usc.2019.4.1Role of Drug-coated Balloons in Small-vessel Coronary Artery DiseaseMichael Megaly0Marwan Saad1Emmanouil S Brilakis2Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN; Division of Cardiovascular Medicine, Hennepin Healthcare, Minneapolis, MNDivision of Cardiovascular Medicine, Department of Medicine, University of Arkansas, Little Rock, AR; Department of Cardiovascular Medicine, Ain Shams University, Cairo, EgyptMinneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MNPercutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.https://www.uscjournal.com/articleindex/usc.2019.4.1
collection DOAJ
language English
format Article
sources DOAJ
author Michael Megaly
Marwan Saad
Emmanouil S Brilakis
spellingShingle Michael Megaly
Marwan Saad
Emmanouil S Brilakis
Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
US Cardiology Review
author_facet Michael Megaly
Marwan Saad
Emmanouil S Brilakis
author_sort Michael Megaly
title Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_short Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_full Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_fullStr Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_full_unstemmed Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
title_sort role of drug-coated balloons in small-vessel coronary artery disease
publisher Radcliffe Medical Media
series US Cardiology Review
issn 1758-3896
1758-390X
publishDate 2019-01-01
description Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.
url https://www.uscjournal.com/articleindex/usc.2019.4.1
work_keys_str_mv AT michaelmegaly roleofdrugcoatedballoonsinsmallvesselcoronaryarterydisease
AT marwansaad roleofdrugcoatedballoonsinsmallvesselcoronaryarterydisease
AT emmanouilsbrilakis roleofdrugcoatedballoonsinsmallvesselcoronaryarterydisease
_version_ 1716830448846372864

Similar Items